Health & Medicine
Researchers develop new treatment for low-risk prostate cancer using drug made from deep sea bacteria
29 Dec 2016
Novel drug may help repair failing hearts
29 Dec 2016
Experimental implant shows promise for restoring voluntary movement after spinal cord injury
28 Dec 2016
A spinal stimulator being tested by doctors at Ronald Reagan University of California at Los Angeles (UCLA) Medical Centre is showing promise in restoring hand strength and movement to a California man who broke his neck in a dirt bike accident five years ago
Light therapy effectively treats early prostate cancer
27 Dec 2016
A new non-surgical treatment for low-risk prostate cancer can effectively kill cancer cells while preserving healthy tissue, reveals a new phase III clinical trial in 413 patients
Should you make sure your doctor is a woman?
26 Dec 2016
Could your doctor's gender have a bearing on your chances of recovery after a visit to the hospital?
AI to generate new cancer drugs on demand
24 Dec 2016
Scientists develop vaccine to counter Ebola
24 Dec 2016
Positive multiple sclerosis clinical trial results support new treatment approach
23 Dec 2016
A new drug slows the progress of multiple sclerosis, including an advanced form of the degenerative nerve disease for which there currently is no treatment
Ancient Chinese malaria remedy fights TB
21 Dec 2016
Latest articles
Featured articles
The decoupling paradox: Why Wall Street keeps funding AI despite $100 oil
By Axel Miller | 11 May 2026
AI infrastructure stocks continue rallying despite $100 oil as investors bet on productivity gains and semiconductor demand in 2026.
Hybrid bonding gains attention as AI chip packaging demand grows
By Cygnus | 23 Apr 2026
Hybrid bonding is driving AI chip packaging demand as backend technologies gain importance in the semiconductor supply chain.
The agentic transition: how enterprises are scaling AI from pilot to profit
By Cygnus | 22 Apr 2026
AI has entered its execution era. Discover how companies like Valeo and Microsoft are scaling agentic AI systems—from copilots to autonomous workflows driving real business impact.
Post-splashdown: What Artemis II taught us about the ‘deep space wall’
By Axel Miller | 15 Apr 2026
Artemis II splashdown marks a breakthrough in deep space exploration. Discover AVATAR radiation data, Orion’s distance record, and insights shaping NASA’s 2028 Moon mission.
Can aviation go green? The multi-billion dollar race for sustainable fuel
By Cygnus | 10 Apr 2026
Airlines are racing to adopt sustainable aviation fuel, but limited supply and high costs challenge the future of green aviation.
The battery race: who will control the future of electric vehicles?
By Axel Miller | 08 Apr 2026
The global battery race is reshaping the electric vehicle industry, with China, the US, and Europe competing for control over supply chains and technology.
AI vs governments: Who controls the future of intelligence?
By Cygnus | 07 Apr 2026
Governments and AI companies like OpenAI and Anthropic are shaping the future of intelligence amid rising policy conflicts and global competition.
Strait of Hormuz: how one chokepoint controls the global economy
By Axel Miller | 06 Apr 2026
The Strait of Hormuz is a critical global chokepoint. Learn how disruptions impact oil prices, shipping, and the global economy.
The $2 trillion AI infrastructure race: Who will control global compute?
By Cygnus | 06 Apr 2026
AI spending is set to exceed $2 trillion in 2026, driving a global race in data centers, chips, and energy infrastructure.
